Photochemical characteristics and substrate properties of four newly synthesized dCTP analogues: N4-[2-(2-nitro-5-azidobenzoylamino)ethyl]-, N4-[2-(4-azidotetrafluorobenzylideneaminooxymethylcarba-moyl)ethyl]-, N 4-[4-(4-azidotetrafluorobenzylidenehydrazinocarbonyl)butylcarbainoyl] -, and N 4-[4-(4-azidotetrafluorobenzylideneaminooxy)butyloxy]-2′- deoxycytidine 5′-triphosphates as well as those of the earlier described N4-[2-(4-azidotetrafluorobenzoylamino)ethyl]- and 5-[E-3-(4-azidotetrafluorobenzoylamino)-l-pro-penyl)]-2′-deoxycytidine 5′-triphosphates were compared. When being irradiated with UV light at a wavelength of 303-313 nm, the new analogues demonstrated greater than 10-fold higher photoactivity as compared with the old compounds. The first three new compounds were utilized by HIV-1 reverse transcriptase as dCTP and dTTP, while the last derivative was recognized only as dTTP. Once incorporated into the primer 3′-terminus, none of the analogues synthesized terminated further primer elongation with natural triphosphates.
|Original language||English (US)|
|Number of pages||9|
|Journal||Russian Journal of Bioorganic Chemistry|
|State||Published - Jul 1 1997|
All Science Journal Classification (ASJC) codes
- Organic Chemistry